Exelixis

Filed a patent for "agents that bind to nkg2a and pd-l1 and uses thereof" on Fri, January 27, 2023

Filed a patent for "nkg2a binding agents and uses thereof" on Fri, January 27, 2023

Filed a patent for "dll3 antibody-drug conjugates and uses thereof" on Wed, March 22, 2023

Filed a patent for "amhrii antibody-drug conjugates and uses thereof" on Wed, March 29, 2023

Filed a patent for "nkg2a binding agents and uses thereof" on Fri, July 7, 2023

Filed a patent for "method of treating renal cell carcinoma using n-(4-(6,7-dimethoxyquinolin-4-yloxy)phenyl)-nã¢â‚¬â„¢-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, (2s)-hydroxybutanedioate" on Thu, October 24, 2024

Filed a patent for "compounds for the treatment of kinase-dependent disorders" on Thu, May 2, 2024

Filed a patent for "crystalline forms and salt forms of a kinase inhibitor" on Thu, September 12, 2024

Filed a patent for "methods of using c-met modulators" on Thu, June 15, 2023

Filed a patent for "anti-tissue factor antibodies, antibody-drug conjugates, and related methods" on Thu, May 25, 2023

Filed a patent for "tissue factor antibody-drug conjugates and uses thereof" on Wed, September 7, 2022

Filed a patent for "methods of treating solid tumors with anti-tissue factor antibody-drug conjugates" on Mon, October 10, 2022

Filed a patent for "liquid dosage forms to treat cancer" on Thu, September 28, 2023

Filed a patent for "processes for the preparation of a kinase inhibitor" on Thu, June 22, 2023

Filed a patent for "multispecific binding agents and uses thereof" on Wed, November 16, 2022

Filed a patent for "compounds for the treatment of kinase-dependent disorders" on Thu, February 8, 2024

Filed a patent for "inflammatory disease treatment using anti-tissue factor antibodies" on Thu, May 23, 2024

Filed a patent for "malate salt of n-(4-{[6,7-bis(methyloxy) quinolin-4-yl]oxy}phenyl)-n'-(4-fluorophenyl)cyclopropane-1,1-dicarboxamide, and crystalline forms thereof for the treatment of cancer" on Thu, June 1, 2023

Filed a patent for "combinations for the treatment of cancer" on Thu, September 28, 2023

Filed a patent for "method of treating cancer" on Thu, October 5, 2023

Filed a patent for "method of treating cancer" on Thu, September 28, 2023

Filed a patent for "c-met modulator pharmaceutical compositions" on Wed, March 1, 2023

Filed a patent for "compounds for the treatment of kinase-dependent disorders" on Thu, May 9, 2024

Filed a patent for "tissue factor antibody-drug conjugates and uses thereof" on Tue, April 25, 2023

Filed a patent for "pharmaceutical compositions of a kinase inhibitor" on Thu, December 14, 2023